Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002970639 | SCV003281510 | pathogenic | not provided | 2024-02-25 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ser294*) in the CTU2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CTU2 are known to be pathogenic (PMID: 31301155, 34356170). This variant is present in population databases (rs201111272, gnomAD 0.04%). This premature translational stop signal has been observed in individual(s) with CTU2-related conditions (PMID: 34356170). ClinVar contains an entry for this variant (Variation ID: 2067774). For these reasons, this variant has been classified as Pathogenic. |
Gene |
RCV002970639 | SCV005377592 | uncertain significance | not provided | 2024-04-15 | criteria provided, single submitter | clinical testing | Observed in the heterozygous state along with a second variant in the CTU2 gene in a patient with intellectual disability, abnormal tone, thinning corpus callosum, growth restriction, and dysmorphic features; however, segregation information was not provided (PMID: 34356170); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 34356170) |